SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
Centre Hospitalier Régional et Universitaire de Nancy · Centre d'Investigation Clinique Pierre Drouin · +17 more institutions
Abstract
No abstract available for this paper.
Citation impact
- FWCI
- 122.07
- Percentile
- 100%
- References
- 17
Authors
11- FZFaı̈ez ZannadCorresponding
Centre Hospitalier Régional et Universitaire de Nancy, Centre d'Investigation Clinique Pierre Drouin, Défaillance Cardiovasculaire Aiguë et Chronique
- JPJoão Pedro Ferreira
Centre Hospitalier Régional et Universitaire de Nancy, Centre d'Investigation Clinique Pierre Drouin, French Clinical Research Infrastructure Network, Défaillance Cardiovasculaire Aiguë et Chronique
- SPStuart Pocock
University of London, London School of Hygiene & Tropical Medicine
- SDStefan D. Anker
German Centre for Cardiovascular Research, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charité - Universitätsmedizin Berlin
- JBJaved Butler
University of Mississippi, Université Bourgogne Franche-Comté, University of Southern Mississippi
Topics & keywords
- Emperor
- Ejection fraction
- Heart failure
- Medicine
- Fraction (chemistry)
- Internal medicine
- Meta-analysis
- Cardiology
- Good health and well-being